RUA Life Sciences PLC

AOHA

Company Profile

  • Business description

    RUA Life Sciences PLC is engaged in contract design and manufacture of medical devices and exploiting the value of its IP and know-how, and developing of cardiovascular devices. Its segments include Biomaterials includes Licensor of Elast-Eon polymers to the medical device industry; Medical Devices and Components engages End-to-end contract developer, manufacturer, and seller of medical devices and implantable fabric specialist; Vascular engages in the development and commercialization of the group’s Elast-Eon sealed Vascular Graft products; and Structural Heart engages in the development of the group’s Elast-Eon composite heart valve material AurTex. Geographically it operates in Europe, North America, Middle East , Asia Pacific, and Africa.

  • Contact

    2 Drummond Crescent
    Ayrshire
    Scotland
    IrvineKA11 5AN
    GBR

    T: +44 1294317073

    E: [email protected]

    https://www.rualifesciences.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    31 March 2026

    Employees

    40

Stocks News & Analysis

stocks

Westpac earnings: Tech overhaul is costly but not hurting lending and deposit growth

Our view after latest earnings report.
stocks

Future Focus: Are franking credits ‘free alpha’?

There’s always an opportunity cost.
stocks

Berkshire Hathaway earnings: Cash balances hit $358 billion on mostly solid results across the firm

We think Berkshire Hathaway stock is moderately undervalued.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,150.1023.90-0.26%
CAC 408,109.7911.28-0.14%
DAX 4024,132.41174.110.73%
Dow JONES (US)47,336.68226.19-0.48%
FTSE 1009,701.3715.88-0.16%
HKSE26,158.36251.710.97%
NASDAQ23,834.72109.770.46%
Nikkei 22552,294.31117.03-0.22%
NZX 50 Index13,643.8687.560.65%
S&P 5006,851.9711.770.17%
S&P/ASX 2008,863.6019.10-0.22%
SSE Composite Index3,976.5221.730.55%

Market Movers